Related Experiment Videos
Relation between bladder cancer and protein oxidation
Ilker A Yilmaz1, Tülay Akçay, Ufuk Cakatay
1Department of Biochemistry, Cerrahpaşa Medical Faculty, University of Istanbul, Istanbul, Turkey. ilkeraydiny@hotmail.com
International Urology and Nephrology
|May 27, 2004
Summary
Bladder cancer patients show lower plasma protein and thiol levels, with higher protein oxidation. Invasive bladder cancer correlates with lower serum iron and protein-bound thiols compared to non-invasive cases.
Area of Science:
- Biochemistry
- Oncology
- Urology
Background:
- Oxidative stress, including DNA, protein, and lipid peroxidation, is implicated in carcinogenesis.
- Inflammatory and oxidative processes play a significant role in the development of bladder cancer.
Purpose of the Study:
- To investigate oxidative stress markers and iron levels in bladder cancer patients compared to a control group.
- To differentiate oxidative stress and iron status between invasive and non-invasive bladder cancer.
Main Methods:
- Quantification of total protein, protein carbonyls, nitrotyrosine, thiol residues, non-protein thiols, and lipid peroxidation.
- Measurement of serum iron and iron-binding levels.
- Statistical comparison between bladder cancer patients and healthy controls, and between invasive and non-invasive subgroups.
Main Results:
- Bladder cancer patients exhibited significantly lower plasma protein levels than controls.
- Patients with bladder cancer showed significantly higher protein carbonyl groups and lower total thiol and protein-bound thiol groups.
- Serum iron levels were significantly lower in invasive bladder cancer patients compared to the non-invasive group, with a more pronounced decline in protein-bound thiols in the invasive subgroup.
Conclusions:
- Oxidative stress markers are altered in bladder cancer patients, indicating a role in the disease.
- Reduced plasma protein and thiol levels, along with increased protein oxidation, are characteristic of bladder cancer.
- Lower serum iron and protein-bound thiols in invasive bladder cancer suggest their potential as indicators for disease progression.